DK164772C - Endo- og ectoparasiticidt parenteralt praeparat indeholdende en avermectin- eller milbemycinforbindelse og fremgangsmaade til fremstilling deraf - Google Patents

Endo- og ectoparasiticidt parenteralt praeparat indeholdende en avermectin- eller milbemycinforbindelse og fremgangsmaade til fremstilling deraf

Info

Publication number
DK164772C
DK164772C DK619784A DK619784A DK164772C DK 164772 C DK164772 C DK 164772C DK 619784 A DK619784 A DK 619784A DK 619784 A DK619784 A DK 619784A DK 164772 C DK164772 C DK 164772C
Authority
DK
Denmark
Prior art keywords
avermectin
ectoparasiticid
endo
preparing
procedure
Prior art date
Application number
DK619784A
Other languages
English (en)
Other versions
DK164772B (da
DK619784A (da
DK619784D0 (da
Inventor
James B Williams
Jr Russell U Nesbitt
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK619784D0 publication Critical patent/DK619784D0/da
Publication of DK619784A publication Critical patent/DK619784A/da
Publication of DK164772B publication Critical patent/DK164772B/da
Application granted granted Critical
Publication of DK164772C publication Critical patent/DK164772C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK619784A 1983-12-22 1984-12-21 Endo- og ectoparasiticidt parenteralt praeparat indeholdende en avermectin- eller milbemycinforbindelse og fremgangsmaade til fremstilling deraf DK164772C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56414083A 1983-12-22 1983-12-22
US56414083 1983-12-22

Publications (4)

Publication Number Publication Date
DK619784D0 DK619784D0 (da) 1984-12-21
DK619784A DK619784A (da) 1985-06-23
DK164772B DK164772B (da) 1992-08-17
DK164772C true DK164772C (da) 1993-01-04

Family

ID=24253315

Family Applications (1)

Application Number Title Priority Date Filing Date
DK619784A DK164772C (da) 1983-12-22 1984-12-21 Endo- og ectoparasiticidt parenteralt praeparat indeholdende en avermectin- eller milbemycinforbindelse og fremgangsmaade til fremstilling deraf

Country Status (17)

Country Link
EP (1) EP0146414B1 (da)
JP (1) JPH0623100B2 (da)
KR (1) KR880002366B1 (da)
AT (1) ATE47522T1 (da)
AU (1) AU560864B2 (da)
CA (1) CA1267844A (da)
DE (1) DE3480263D1 (da)
DK (1) DK164772C (da)
ES (1) ES8608888A1 (da)
GR (1) GR81244B (da)
HK (1) HK5091A (da)
IE (1) IE57681B1 (da)
IL (1) IL73800A (da)
NZ (1) NZ210505A (da)
PT (1) PT79656B (da)
SG (1) SG97890G (da)
ZA (1) ZA849841B (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3883408T2 (de) * 1987-01-23 1993-12-09 Pfizer Verfahren zur Herstellung von Avermectinen und die verwendeten Kulturen.
US5075307A (en) * 1987-07-28 1991-12-24 Merck & Co., Inc. Paraherquamide and dihydroparaherquamide as antihelminthic agents
GB8803836D0 (en) * 1988-02-18 1988-03-16 Glaxo Group Ltd Compositions
US6001822A (en) * 1989-04-11 1999-12-14 Pfizer Inc. Antiparasitic formulations
US5169846A (en) * 1989-10-12 1992-12-08 Crooks Michael J Non-aqueous micellar solutions of anthelmintic benzimidazoles, closantel, or phenothiazine, and insect growth regulators
NZ335166A (en) 1999-04-14 2001-11-30 Ashmont Holdings Ltd Anthelmintic composition containing triclabendazole in at least one solvent
GB2275193A (en) * 1993-02-17 1994-08-24 Merck & Co Inc Formulations for the topical delivery of avermectins
PL174488B1 (pl) * 1993-05-10 1998-08-31 Merck & Co Inc Preparat do zwalczania pasożytów zwierząt oraz sposób wytwarzania preparatu do zwalczania pasożytów zwierząt
PL173487B1 (pl) * 1993-05-10 1998-03-31 Merck & Co Inc Preparat do zwalczania wewnętrznych i zewnętrznych pasożytów zwierząt, sposób wytwarzania preparatu do zwalczania wewnętrznych i zewnętrznych pasożytów zwierząt oraz sposób zwalczania zewnętrznych pasożytów zwierząt
US5602107A (en) * 1993-05-10 1997-02-11 Merck & Co., Inc. Pour-on formulations consisting of gylcols, glycerides and avermectin compounds
DE19613972A1 (de) * 1996-04-09 1997-10-16 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl
DE19638045A1 (de) * 1996-09-18 1998-03-19 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen
US6054140A (en) * 1997-03-21 2000-04-25 Biogenesis S.A. Long acting injectable parasiticidal composition and the process for its preparation
WO1999002182A2 (en) * 1997-07-10 1999-01-21 Biotech Australia Pty. Limited Non-aqueous vaccines
GB9816132D0 (en) * 1998-07-24 1998-09-23 Norbrook Lab Ltd Non-aqueous anthelmintic composition
AU7463000A (en) * 1999-09-22 2001-04-24 Ashmont Holdings Limited Sheep pour-on
JP2001253824A (ja) * 2000-03-14 2001-09-18 Mitsukazu Matsumoto 局所注射用処方剤
GR1003969B (el) * 2001-02-05 2002-08-14 U��-Pharma ����� ������ ������������ ���������� ���� Σταθερα φαρμακευτικα διαλυματα νιμεσουλιδης.
US20050009762A1 (en) 2003-06-06 2005-01-13 Strobel Michael Albert Application of water and organic solvent soluble ivermectin for topical and oral use
US6627613B2 (en) 2001-07-23 2003-09-30 Michael A. Strobel Application of water and organic solvent soluble ivermectin for topical and oral use
GB2386066A (en) 2002-02-28 2003-09-10 Norbrook Lab Ltd Long-acting parasiticidal composition with improved bioavailability comprising a salicylanilide, a further anti-parasitic compound & a polymeric species
UY27412A1 (es) * 2002-08-12 2003-06-30 Carlson Internat Inc Un nuevo producto para el combate de garrapatas y el proceso para la prepaacinn.
GB0316377D0 (en) 2003-07-12 2003-08-13 Norbrook Lab Ltd Parasiticidal composition
JP4886214B2 (ja) * 2005-05-24 2012-02-29 日本パワーファスニング株式会社 石膏ボード締結用の２条式木ねじ
AU2009245834B2 (en) 2008-10-08 2013-11-14 Zoetis Services Llc Benzimidazole anthelmintic compositions
JP5607114B2 (ja) 2012-06-26 2014-10-15 株式会社トープラ タッピンねじ
JP2024516912A (ja) 2021-05-14 2024-04-17 シンジェンタ クロップ プロテクション アクチェンゲゼルシャフト 昆虫、ダニ目及び線虫有害生物の防除
WO2022268815A1 (en) 2021-06-24 2022-12-29 Syngenta Crop Protection Ag Insect, acarina and nematode pest control

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4144352A (en) * 1977-12-19 1979-03-13 Merck & Co., Inc. Milbemycin compounds as anthelmintic agents
US4130651A (en) * 1978-03-31 1978-12-19 American Cyanamid Company Butamisole injectable formulations having improved margin of safety in dogs
NZ197796A (en) * 1980-08-04 1984-11-09 Merck & Co Inc Stabilised aqueous formulations containing ivermectin
US4430329A (en) * 1982-05-17 1984-02-07 Merck & Co., Inc. Synergistic treatment of adult canine heartworm with thiacetarsamide and ivermectin

Also Published As

Publication number Publication date
EP0146414B1 (en) 1989-10-25
PT79656B (en) 1987-01-16
SG97890G (en) 1991-02-14
AU3702484A (en) 1985-07-04
ATE47522T1 (de) 1989-11-15
IE843221L (en) 1985-06-22
IL73800A0 (en) 1985-03-31
DK164772B (da) 1992-08-17
KR880002366B1 (ko) 1988-11-03
IE57681B1 (en) 1993-02-24
ZA849841B (en) 1986-07-30
IL73800A (en) 1987-11-30
HK5091A (en) 1991-01-18
EP0146414A3 (en) 1986-12-10
ES8608888A1 (es) 1986-07-16
PT79656A (en) 1985-01-01
AU560864B2 (en) 1987-04-16
KR850004391A (ko) 1985-07-15
JPS60169415A (ja) 1985-09-02
NZ210505A (en) 1988-06-30
DK619784A (da) 1985-06-23
ES538750A0 (es) 1986-07-16
EP0146414A2 (en) 1985-06-26
DE3480263D1 (en) 1989-11-30
CA1267844A (en) 1990-04-17
JPH0623100B2 (ja) 1994-03-30
GR81244B (en) 1985-04-16
DK619784D0 (da) 1984-12-21

Similar Documents

Publication Publication Date Title
DK164772C (da) Endo- og ectoparasiticidt parenteralt praeparat indeholdende en avermectin- eller milbemycinforbindelse og fremgangsmaade til fremstilling deraf
IT1173705B (it) Formulazione farmaceutica di clometacina per somministrazione orale e procedimento di preparazione
NO871267L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazepinforbindelser.
NO871266D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO870526L (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater.
DK281184A (da) Galeniske praeparatformer for orale antidiabetica og fremgangsmaade til deres fremstilling
SE8406538D0 (sv) Novel derivatives of purine
NO874032D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater.
DK140393A (da) Ioderet uracilnicleosid, denne forbindelse til anvendelse mod en adenovirusinfektion, anvendelse af forbindelsen til fremstilling af et lægemiddel mod en adenovirusinfektion, farmaceutisk præparater indeholdende forbindelsen samt fremgangsmåde til fremstilling af forbindelsen
NO883485D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinyl-isokinolinforbindelser.
DK157482A (da) Galenisk praeparat indeholdende gallopamil eller verapamil og fremgangsmaade til fremstilling heraf
NO875488D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
NO885598D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive ammoniumforbindelser.
NO880667D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylpiperazinyl-alkylen-fenyl-heterocykliske forbindelser.
NO884176D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive amidinoderivater.
NO873514D0 (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive forbindelser.
ES2040774T3 (es) Procedimiento para la preparacion de una formulacion medicamentosa.
NO160142C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive (1,2,4)triazolo(4,3-a)kinoksalin-4-amin-derivater.
NO166366C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cycloalkan (1,2-c:4,3-c')dipyrazoler.
NO167511C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte tieno(3,4-d)imidazolderivater.
DK69287A (da) Temazepamkomposition og fremgangsmaade til fremstilling af samme